Tactical Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
48 Wall St Fl 12, New York City, New Yor...Phone Number
(212) 651-9653Website
www.tacticaltherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Tactical Therapeutics
Tactical Therapeutics specializes in developing innovative therapies aimed at overcoming resistance in malignant brain cancer, particularly glioblastoma. They focus on a first-in-class inhibitor of calcium signaling to tackle solid cancers effectively. Their products are intended for use in challenging oncology cases where traditional treatments may fail. The company is dedicated to advancing cancer treatment options for patients affected by aggressive tumors.Explore more
Tactical Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tactical Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Tactical Therapeutics
Earning: See what the market has to say on Tactical Therapeutics recently announced quarterly report
Tactical Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Tactical Therapeutics launches new products
Check out if Tactical Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tactical Therapeutics had a recent Job posting/layoffs
Check if Tactical Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tactical Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Tactical Therapeutics
Compare insights from companies similar to Tactical Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tactical Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tactical Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tactical Therapeutics.
Tactical Therapeutics Tech Stack
A closer look at the technologies used by Tactical Therapeutics
Tactical Therapeutics News & Media
Tactical Therapeutics, Inc., Developer of CTO Treatments for Glioblastoma, Selected to Present at MedInvest Oncology Investor Conference December 14-15 in New York
Founder and CEO Rashida Karmali Ph.D., J.D., is a respected pioneer in cancer research, specializing in drug discovery and development Carboxyamidotriazole Orotate (CTO) shows promising results in pre-clinical and Phase I trials A privately funded clinical stage company, TTI is raising...Tactical Therapeutics Announces Publication of Promising Results of Phase IB Trials of Carboxyamidotriaxole Orotate (CTO) in Glioblastomas
NEW YORK--(BUSINESS WIRE)--Tactical Therapeutics, Inc., a clinical stage biopharma, announced publication of “Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas” in the Journal of Clinical Oncology. (jco.ascopubs.org) Phase IB studies on CTO commenced in 2013 at Memorial Sloan-Kettering Cancer Center, New York, enrolling 27 patients with recurrent GBM (rGBM) and 15 with newly diagnosed GBM (nGBM
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tactical Therapeutics
Sign Up For FreeTo access detailed company insights
Tactical Therapeutics specializes in developing innovative therapies aimed at overcoming resistance in malignant brain cancer, particularly glioblastoma. They focus on a first-in-class inhibitor of calcium signaling to tackle solid cancers effectively. Their products are intended for use in challenging oncology cases where traditional treatments ma... Read More
